For example, monoclonal antibodies that bind the EGFR extracellular domain can promote downregulation [40,41], and the endocytosis of EGFR induced by EGF is closely related to the sensitivity to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer cell lines [42]. Here, EGFR is linked to non-small cell lung carcinoma.